Emerging Treatment Options in Inflammatory Bowel Disease

Nov 23, 2020 | health and medicine, Karger Publishers

In Collaboration With

Original Article Reference

This SciPod is a shortened and simplified summary of ‘Emerging Treatment Options in Inflammatory Bowel Disease’, published by Karger Publishers https://doi.org/10.1159/000507782

The complete original works are available at www.karger.com

About this episode

Inflammatory bowel disease (IBD) is a group of gastrointestinal conditions affecting almost 7 million people globally, and this incidence is rising. While treatments have improved over the last century, many patients do not respond sufficiently, especially those with moderate to severe levels of the disease. Novel drugs that restrain the immune system and reduce inflammation are being developed with the hope of improving patient outcomes. Dr Benjamin Misselwitz at Island Hospital of Bern and Bern University and his colleagues have conducted a comprehensive review of the emerging therapies and make recommendations for improving treatment for a wider range of patients.

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Related episodes

Professor François Vialard  | Unraveling Azoospermia: Using Genetics to Avoid Futile Sperm Extraction

Professor François Vialard | Unraveling Azoospermia: Using Genetics to Avoid Futile Sperm Extraction

For many couples struggling to conceive, a male infertility diagnosis can feel like a closed door. Roughly half of all infertility cases worldwide stem from male factors, and among these, one of the most frustrating conditions is non-obstructive azoospermia (or NOA for short), a complete absence of sperm caused not by a physical blockage but by a failure of sperm production itself. Until recently, most men with NOA were offered a potentially painful and uncertain procedure called testicular sperm extraction (or TESE). In this surgery, doctors search directly within the testis for a few viable sperm cells that can be used for in vitro fertilization. When successful, the results can be life-changing. When unsuccessful, it is physically invasive, emotionally draining, and often repeated several times in vain.

Prof. Jim Oates | When Blood Vessels Speak: How Lupus Turns the Body’s Gatekeepers into Active Messengers of Inflammation

Prof. Jim Oates | When Blood Vessels Speak: How Lupus Turns the Body’s Gatekeepers into Active Messengers of Inflammation

You may imagine your vasculature as a vast and silent network of tubes, dutifully carrying blood, oxygen, and nutrients to every organ and tissue. These vessels seem purely mechanical, like plumbing hidden behind walls, doing their job quietly and invisibly. Yet modern biology has revealed a far richer and more surprising reality. Blood vessels are lined with living, sensing, responding cells called endothelial cells, and these cells are anything but passive. They listen to chemical signals, respond to stress, regulate traffic, and communicate constantly with the immune system.

Prof. Stephen Graham | From Hospitals to Households: How Decentralised Care Is Transforming Tuberculosis Treatment for Children

Prof. Stephen Graham | From Hospitals to Households: How Decentralised Care Is Transforming Tuberculosis Treatment for Children

Tuberculosis remains one of the world’s oldest and most stubborn infectious diseases, yet the way health systems respond to it is often dogged by modern challenges. Clinics are overcrowded, families must travel long distances, and children with vague or non-specific symptoms are frequently overlooked. For decades, tuberculosis care has been organised around hospitals and specialised facilities, even though the disease itself spreads and takes root in homes and communities. A growing body of research now argues that this mismatch is costing lives, particularly among children. Decentralised models of care, which bring services closer to families and empower community-based health workers, offer a compelling alternative. Recent evidence from multiple settings shows that when tuberculosis care is shifted out of distant clinics and into neighbourhoods and households, access expands with potential to close the current gaps in TB detection, treatment outcomes and prevention that benefit communities and families, including their children.

Dr. Jürgen Gailer | Linking the Blood Chemistry of Metals with Adverse Human Health: New Tools Reveal an Invisible World

Dr. Jürgen Gailer | Linking the Blood Chemistry of Metals with Adverse Human Health: New Tools Reveal an Invisible World

Researchers Maryam Doroudian and Jürgen Gailer from the University of Calgary explore what happens when red blood cells rupture and release a zinc-containing enzyme called carbonic anhydrase 1 into the bloodstream, revealing that it remains unexpectedly free and may influence vascular health. Their work also connects to broader research showing how liquid chromatography is transforming our ability to study toxic cadmium and mercury as they move through the body. Together, these studies uncover hidden biochemical processes that shape how environmental pollutants and blood-cell damage affect human health.